Group One Trading’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.6K Hold
11,300
﹤0.01% 5738
2025
Q4
$15.5K Buy
11,300
+7,200
+176% +$9.5K ﹤0.01% 6546
2025
Q3
$5.08K Sell
4,100
-38,500
-90% -$45.9K ﹤0.01% 7535
2025
Q2
$48.1K Sell
42,600
-49,300
-54% -$65.5K ﹤0.01% 5608
2025
Q1
$134K Sell
91,900
-38,500
-30% -$72.6K ﹤0.01% 4366
2024
Q4
$278K Buy
130,400
+118,600
+1,005% +$293K ﹤0.01% 3656
2024
Q3
$33K Buy
11,800
+6,700
+131% +$17.9K ﹤0.01% 4929
2024
Q2
$11.9K Sell
5,100
-66,500
-93% -$196K ﹤0.01% 5549
2024
Q1
$320K Buy
71,600
+51,900
+263% +$217K ﹤0.01% 3157
2023
Q4
$63.2K Sell
19,700
-14,000
-42% -$39.7K ﹤0.01% 4874
2023
Q3
$107K Buy
33,700
+13,900
+70% +$60.9K ﹤0.01% 4394
2023
Q2
$98.4K Buy
19,800
+17,700
+843% +$95.7K ﹤0.01% 4639
2023
Q1
$10.4K Hold
2,100
﹤0.01% 5912
2022
Q4
$13.2K Sell
2,100
-6,800
-76% -$63K ﹤0.01% 5873
2022
Q3
$96K Sell
8,900
-4,200
-32% -$57.1K ﹤0.01% 4815
2022
Q2
$149K Buy
13,100
+3,700
+39% +$32.8K ﹤0.01% 4580
2022
Q1
$86K Sell
9,400
-6,300
-40% -$65.6K ﹤0.01% 5638
2021
Q4
$234K Buy
15,700
+12,100
+336% +$213K ﹤0.01% 4930
2021
Q3
$93K Sell
3,600
-5,000
-58% -$119K ﹤0.01% 5975
2021
Q2
$224K Buy
8,600
+3,200
+59% +$91.3K ﹤0.01% 5123
2021
Q1
$191K Buy
5,400
+3,400
+170% +$115K ﹤0.01% 5075
2020
Q4
$50K Buy
2,000
+1,000
+100% +$32.6K ﹤0.01% 4998
2020
Q3
$38K Sell
1,000
-200
-17% -$7.54K ﹤0.01% 4802
2020
Q2
$51K Buy
+1,200
New +$43.4K ﹤0.01% 4341
2020
Q1
Sell
-1,400
Closed -$36K 5186
2019
Q4
$36K Sell
1,400
-800
-36% -$22K ﹤0.01% 4150
2019
Q3
$60K Buy
2,200
+200
+10% +$5.7K ﹤0.01% 3882
2019
Q2
$54K Buy
2,000
+700
+54% +$19.5K ﹤0.01% 3730
2019
Q1
$38K Buy
+1,300
New +$37.7K ﹤0.01% 3691

Other funds holding ALLO